NCT06836557View on ClinicalTrials.gov

Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis

PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 9, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Idiopathic GastroparesisDiabetic GastroparesisGastroparesis
Interventions
DRUG

Tradipitant

BID

Trial Locations (3)

3000

RECRUITING

Vanda Investigational Site, Leuven

4000

RECRUITING

Vanda Investigational Site, Liège

04103

RECRUITING

Vanda Investigational Site, Leipzig

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY